Skip to content
Search AI Powered

Latest Stories

Paul Adams appointed as new CEO of LloydsPharmacy Clinical Homecare

Paul Adams appointed as new CEO of LloydsPharmacy Clinical Homecare

Adams is committed to creating healthcare systems that are both efficient and empathetic

LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the company’s new Chief Executive Officer (CEO).


Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.

With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies. He has also co-authored “The Little Black Book of Change.”

Adams will lead the LPCH’s mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within homecare and community settings while improving accessibility.

Adams said: "It’s a privilege to step into a role that has such a profound impact on the way healthcare is delivered.

"Our aim is to ensure that every patient has access to the vital healthcare they need, right in their own communities or homes, not only easing the load on the NHS but improving healthcare outcomes.”

LloydsPharmacy Clinical Homecare provides a comprehensive range of healthcare services, including specialist cancer care, clinical homecare, remote nursing, and community-based solutions.

Adams' leadership is expected to help the organisation further innovate its service delivery model, ensuring healthcare is even more responsive to the to the diverse needs of patients nationwide.

Adams strongly supports harnessing new digital-enabled capabilities to streamline the entire patient journey during their treatment, creating seamless interactions with both hospitals and private medical services.

"The adoption of digital solutions within the healthcare environment itself presents a major challenge, but this is something we are keen to do more of, given its importance in modernising healthcare services," Adams said.

Driven by a passion for creating healthcare systems that are both efficient and empathetic, Adams aims to infuse LloydsPharmacy Clinical Homecare with a culture of innovation, operational excellence, and a relentless focus on patient care.

"Healthcare must evolve to meet the changing demands of our society. I am committed to leading the organisation in a way that not only meets those demands but anticipates and addresses future healthcare needs,” he said.

“Demand for homecare services will only grow, and the services we offer are vital. They play a part in the country’s fabric of healthcare, and they can’t be replaced easily,” he added.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less